Profile data is unavailable for this security.
About the company
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
- Revenue in USD (TTM)10.06m
- Net income in USD1.96m
- Incorporated1987
- Employees24.00
- LocationUnited-Guardian Inc230 Marcus BlvdHAUPPAUGE 11788United StatesUSA
- Phone+1 (631) 273-0900
- Fax+1 (631) 273-0858
- Websitehttps://u-g.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicus Pharma Ltd | -100.00bn | -100.00bn | 23.86m | -- | -- | -- | -- | -- | -- | -- | -- | -0.0434 | -- | -- | -- | -- | -- | -361.95 | -- | -- | -- | -- | -- | -- | -- | -- | 1.13 | -- | -- | -- | -109.90 | -- | -- | -- |
| Aytu Biopharma Inc | 62.64m | -24.56m | 24.36m | 82.00 | -- | 1.72 | -- | 0.389 | -3.40 | -3.39 | 5.63 | 1.32 | 0.5259 | 2.10 | 2.22 | 763,902.40 | -20.62 | -26.47 | -45.22 | -47.32 | 66.84 | 60.56 | -39.21 | -52.54 | 1.03 | 0.057 | 0.5958 | -- | 1.84 | 19.16 | -13.27 | -- | -- | -- |
| Dare Bioscience Inc | 27.69k | -17.46m | 24.58m | 21.00 | -- | 8.38 | -- | 887.59 | -1.92 | -1.92 | 0.0029 | 0.2052 | 0.0011 | -- | 0.0624 | 1,318.57 | -71.56 | -91.64 | -241.96 | -243.93 | 127.70 | -- | -63,069.55 | -1,024.05 | -- | -156.39 | 0.7177 | -- | -99.65 | -- | 86.56 | -- | -- | -- |
| TherapeuticsMD Inc | 2.80m | 73.00k | 28.13m | 1.00 | 389.42 | 1.02 | 61.14 | 10.06 | 0.0062 | 0.0261 | 0.2419 | 2.37 | 0.0715 | -- | 0.8002 | 2,796,000.00 | 0.1867 | -42.65 | 0.2169 | -112.14 | -- | -- | 2.61 | -193.47 | -- | -5,240.00 | 0.00 | -- | 35.25 | -48.72 | 69.97 | -- | -- | -- |
| Healthy Extracts Inc | 3.59m | -1.17m | 29.19m | 2.00 | -- | 1.21 | -- | 8.13 | -0.3195 | -0.3195 | 0.9095 | 1.43 | 0.2505 | 1.42 | 140.67 | 1,794,555.00 | -8.19 | -61.21 | -9.09 | -111.60 | 52.37 | 51.30 | -32.71 | -82.01 | 0.6491 | -2.84 | 0.0421 | -- | 25.24 | 32.99 | 66.01 | -- | -- | -- |
| United-Guardian Inc | 10.06m | 1.96m | 30.41m | 24.00 | 15.52 | 2.87 | 14.74 | 3.02 | 0.4266 | 0.4266 | 2.19 | 2.30 | 0.7911 | 3.82 | 7.58 | 419,180.40 | 15.41 | 26.91 | 17.85 | 31.16 | 50.60 | 54.16 | 19.48 | 26.97 | 6.16 | -- | 0.00 | 92.34 | 11.91 | -2.18 | 25.94 | -7.35 | 30.65 | -8.64 |
| Kyntra Bio Inc | 8.30m | -131.13m | 31.55m | 225.00 | -- | -- | -- | 3.80 | -32.49 | 53.34 | 2.05 | -4.21 | 0.0413 | -1.47 | 0.421 | 36,880.00 | -64.00 | -39.47 | -260.98 | -61.33 | 345.69 | 90.21 | -1,548.18 | -199.02 | 3.60 | -- | 0.5269 | -- | -36.71 | -35.07 | 52.60 | -- | -45.94 | -- |
| SCYNEXIS Inc | 2.93m | -25.30m | 33.56m | 28.00 | -- | 0.9211 | -- | 11.45 | -0.5107 | -0.5107 | 0.0593 | 0.8683 | 0.0391 | -- | 0.5776 | 104,714.30 | -33.71 | -20.51 | -43.65 | -24.97 | 33.32 | -- | -862.89 | -64.82 | -- | -- | 0.00 | -- | -97.33 | 98.68 | -131.75 | -- | -- | -- |
| Hyperion DeFi Inc | 345.32k | -26.40m | 34.06m | 13.00 | -- | 0.407 | -- | 98.63 | -20.32 | -20.32 | 0.0385 | 9.88 | 0.0065 | -- | 1.06 | 26,563.08 | -48.31 | -102.28 | -59.47 | -168.53 | -798.11 | 60.58 | -7,385.51 | -856.97 | -- | -- | 0.0976 | -- | 1,412.93 | -- | -82.75 | -- | -0.6271 | -- |
| BioXcel Therapeutics Inc | 752.00k | -68.21m | 35.43m | 37.00 | -- | -- | -- | 47.11 | -10.41 | -10.41 | 0.1023 | -4.45 | 0.016 | 0.9718 | 501.33 | 20,324.32 | -145.62 | -76.45 | -449.90 | -88.28 | -28.19 | -- | -9,070.61 | -14,760.23 | 1.16 | -3.25 | 5.40 | -- | 64.20 | -- | 66.71 | -- | -- | -- |
| Celularity Inc | 40.58m | -80.71m | 36.05m | 123.00 | -- | -- | -- | 0.8883 | -3.34 | -3.34 | 1.69 | -0.7121 | 0.3339 | 6.14 | 5.24 | 329,902.40 | -66.35 | -23.42 | -158.76 | -26.83 | 50.61 | -- | -198.75 | -294.70 | 0.123 | -6.57 | 2.01 | -- | 138.11 | -- | 70.51 | -- | -- | -- |
| Talphera Inc | 28.00k | -12.46m | 37.88m | 13.00 | -- | 1.93 | -- | 1,352.84 | -0.3808 | -0.378 | 0.0009 | 0.4207 | 0.0011 | -- | -- | 2,153.85 | -48.15 | -14.86 | -54.44 | -19.40 | -- | -- | -44,503.57 | -446.19 | -- | -- | 0.00 | -- | -100.00 | -- | -26.41 | -- | -- | -- |
| Elutia Inc | 21.08m | -22.99m | 38.44m | 51.00 | -- | -- | -- | 1.82 | -0.6006 | -0.6827 | 0.5347 | -1.03 | 0.5419 | 4.04 | 6.50 | 413,411.80 | -59.08 | -57.79 | -- | -128.41 | 45.97 | 42.77 | -109.03 | -92.86 | 0.396 | -- | -- | -- | -1.50 | -10.69 | -31.23 | -- | 2.54 | -- |
| Telomir Pharmaceuticals Inc | 0.00 | -11.25m | 38.51m | -- | -- | 5.43 | -- | -- | -0.3739 | -0.3739 | 0.00 | 0.2063 | 0.00 | -- | -- | -- | -266.47 | -- | -303.19 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.48 | -- | -- | -- |
| Earth Science Tech Inc | 33.84m | 2.81m | 39.56m | 76.00 | 14.66 | 7.92 | 12.80 | 1.17 | 0.0092 | 0.0092 | 0.1114 | 0.0171 | 4.93 | 12.73 | 156.99 | 445,269.50 | 40.56 | 24.04 | 66.31 | -- | 72.21 | 71.08 | 8.22 | 5.50 | 0.7202 | 7.06 | 0.009 | -- | 177.05 | 128.98 | 300.63 | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to United-Guardian Inc's reporting currency: US Dollar USD
18.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 30 Sep 2025 | 184.76k | 4.02% |
| GAMCO Asset Management, Inc.as of 31 Dec 2025 | 162.50k | 3.54% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 130.47k | 2.84% |
| Rodgers Brothers, Inc. (Investment Management)as of 30 Sep 2025 | 82.27k | 1.79% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 73.95k | 1.61% |
| Teton Advisors LLCas of 31 Dec 2025 | 53.76k | 1.17% |
| Parthenon LLCas of 31 Dec 2025 | 50.64k | 1.10% |
| Gabelli Funds LLCas of 31 Dec 2025 | 38.00k | 0.83% |
| Geode Capital Management LLCas of 30 Sep 2025 | 32.87k | 0.72% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2025 | 21.19k | 0.46% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
